BioAtla® develops novel cancer therapeutics that meet critical needs including improved safety and the treatment of previously undruggable cancers.Learn more
BioAtla® and Sinobioway Expand Collaboration Agreement and Enter Into Services AgreementLearn more
We are Hiring!
At BioAtla® we recognize that the success of our business depends on the excellence of our people, and are dedicated to recruiting exceptional talent for our team.Learn more
BioAtla mentioned in the mediaLearn more
Conditionally Active Biologics™ (CAB’s)
BioAtla®’s revolutionary platform for developing conditionally active therapeutics yields antibodies (or other biologics) that can be activated or inactivated under defined physiological conditions.Learn more